Marvin W Kronenberg Selected Research

Heart Failure

12/2022	Effect of nitroglycerin on splanchnic and pulmonary blood volume.
3/2017	Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.
12/2013	Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy.
1/2013	Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.
5/2012	Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.
4/2012	Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
6/2007	Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
3/2004	Selection of patients for heart transplantation in the current era of heart failure therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marvin W Kronenberg Research Topics

Disease

8	Heart Failure 12/2022 - 03/2004
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2021 - 12/2013
2	Starvation 08/2014 - 12/2013
2	Myocardial Infarction 01/2013 - 05/2012
1	Chest Pain (Chest Pains) 01/2022
1	Chylothorax 01/2022
1	Inflammation (Inflammations) 01/2022
1	Fibrosis (Cirrhosis) 03/2017
1	2 Gingival Fibromatosis 01/2013
1	Chronic Limb-Threatening Ischemia 05/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2012
1	Left Ventricular Dysfunction 04/2012

Drug/Important Bio-Agent (IBA)

3	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 03/2017
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 08/2014
1	Radioisotopes (Radionuclides)IBA 12/2022
1	Nitroglycerin (Dynamite)FDA LinkGeneric 12/2022
1	Troponin IIBA 01/2022
1	GadoliniumIBA 03/2017
1	Adenosine (Adenocard)FDA LinkGeneric 12/2014
1	Acetates (Acetic Acid Esters)FDA Link 12/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	NeuregulinsIBA 01/2013
1	Neuregulin-1 (Neuregulin 1)IBA 01/2013
1	Vasopressins (Vasopressin)IBA 06/2007
1	Tolvaptan FDA Link 06/2007
1	A-factor (Streptomyces)IBA 06/2007

Therapy/Procedure

8	Therapeutics 01/2021 - 03/2004
1	Pneumonectomy (Lung Volume Reduction) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2012
1	Injections 04/2012
1	Heart Transplantation (Grafting, Heart) 03/2004